Bookmark

Add to MyYahoo RSS

J and J Snack Foods News

News on J and J Snack Foods (Ticker: JJSF) continually updated from thousands of sources around the net.

Saturday | Courier News

Walter Joppy of J&J it Services support children in needWalter Joppy...

Walter Joppy of J&J IT Services support children in need Walter Joppy of J&J IT Services was this year's CASAblanca honoree Check out this story on mycentraljersey.com: http://mycj.co/1mPHEK7 Photo from left: Deb Cummins , Kelly Spillman , Lori Ross , Walter Joppy , Janet Wesselmann , and Tracey Heisler are shown at the recent 6th annual CASAblanca ... (more)

Comment?

Related Topix: Food, Basking Ridge, NJ

Fri Jul 25, 2014

Reuters

Europe backs new leukaemia drugs from J&J and Gilead

Two new leukaemia drugs from Johnson & Johnson and Gilead Sciences have been recommended for approval by European regulators, paving the way for formal approval in a couple of months.

Comment?

Related Topix: Biotech, Medicine, Gilead Sciences, Healthcare Industry, Food, Johnson & Johnson, Johnson and Johnson, Johnson and Johnson Merck Consumer Pharmaceuticals

Thu Jul 24, 2014

The Motley Fool

Why Organovo Holdings Inc Stock Bulked Up Today

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

Comment?

Related Topix: Food

Theflyonthewall.com

Organovo jumps 19% to $9.13 following agreement with J&J unit

Organovo enters 3D bio-printed tissue agreement with J&J unit Organovo announced that it has entered into an agreement with Janssen Research and Development, a pharmaceutical company of Johnson & Johnson , to evaluate the use of 3D bio-printed tissue in a drug discovery setting, outside of the company's work in 3D liver tissue for toxicity testing.

Comment?

Related Topix: Food, Biotech, Johnson and Johnson, Medicine, Healthcare Industry

Wed Jul 23, 2014

GuruFocus.com

3 Dividend Stocks For Retirement

As the US economy continues to post evidence of recovery, the Federal Reserve has more options available in defining its monetary policy strategies.

Comment?

Related Topix: Financial Markets, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Food

Tue Jul 22, 2014

The Motley Fool

Do This Drug's Sales Make J&J a Hepatitis C Powerhouse?

So why, you may ask, did the shares tank by 2%? As so often happens in the financial universe, I believe the reaction had more to do with perception than reality.

Comment?

Related Topix: Food

The Motley Fool

Tuesday's Top Health Care Stocks: Herbalife, Exact Sciences, AstraZeneca, J&J

During an interview on "Bottom Line" yesterday, Ackman announced that he would show how Herbalife's Nutrition Clubs were equivalent to Enron's fake trading rooms.

Comment?

Related Topix: Food, Financial Markets, Marketing, Sales, Healthcare Law, Law

Mon Jul 21, 2014

Courier News

Heartbeats: Public campaign underway for Saint Peter'sHeartbeats:...

Heartbeats: Public campaign underway for Saint Peter's Health news from New Brunswick, Bernards, Branchburg, Woodbridge, Central Jersey Check out this story on mycentraljersey.com: http://mycj.co/1mydYkp The new and expanded Pediatric Emergency Department at Saint Peter's University Hospital in New Brunswick was completed in the spring of 2013 and ... (more)

Comment?

Related Topix: Medicine, Saint Peter's University Hospital, Hospital Administration, Healthcare Industry, New Brunswick, NJ, Women's Health, Health, Johnson & Johnson, Food

MSN Money

J&J buying back $5 billion worth of its shares

Johnson & Johnson, the world's biggest maker of health care products, plans to buy back up to $5 billion of the company's common stock.

Comment?

Related Topix: Food, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

GuruFocus.com

Two Food Companies That Can Deliver Long-Term Growth

The packaged food industry in the U.S. is experiencing a solid boom, mainly because of the lack of time people have due to a busy lifestyle and rising commodity prices.

Comment?

Related Topix: Food, ConAgra Foods, Agriculture, Rah

Fri Jul 18, 2014

The Motley Fool

3 Crucial Questions Johnson & Johnson Needs to Answer

But with any company as big as J&J, not every investor question can be answered, and sometimes the leftover question marks are pretty big.

Comment?

Related Topix: Food

Thu Jul 17, 2014

Adweek

Johnson's Baby Latches on to Royal Toddler's Birthday to Build Social Strategy

New moms sometimes go overboard with taking and sharing photos of their kids on social media.

Comment?

Related Topix: Family, Kids, Food, Marketing, Startups, Facebook, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry

Wed Jul 16, 2014

JD Supra

Mergers and Acquisitions Under the FCPA, Part III

Today I conclude my three-part series on mergers and acquisitions under the Foreign Corrupt Practices Act with a review of the post-acquisition phase.

Comment?

Related Topix: Food, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry

The China Post

JandJ 2Q profit climbs 13% on new drug sales

Strong sales of several new drugs, particularly its hot new hepatitis medicine, lifted Johnson & Johnson's second-quarter profit by 13 percent, topping analysts' expectations.

Comment?

Related Topix: Food

Refrigerated & Frozen Foods

New Twist to Old Favorites

A new twist to pretzels J&J Snack Foods Corp., Pennsauken, N.J., introduced a new twist to its S UPERPRETZEL brand.

Comment?

Related Topix: Food, Pennsauken, NJ, Life, Seafood, Baked Goods, Bread, Bar-B-Q

The Motley Fool

A Surprising Johnson & Johnson Stock Growth Driver, Revealed

But it wasn't just Olysio that drove growth. This 'sleepy' business segment turned in 6% worldwide growth at constant currency .

Comment?

Related Topix: Food

Freshnews

Mark H.N. Corrigan, M.D., Julie H. McHugh, and William Hunter, M.D....

EPIRUS Biopharmaceuticals, Inc. , a Boston-based biopharmaceutical company focused on the global development and commercialization of biosimilar monoclonal antibodies, announced that Mark H.N. Corrigan, M.D., Julie H. McHugh, and William Hunter, M.D. will serve on its board of directors.

Comment?

Related Topix: Biotech, CombinatoRx, Medicine, Healthcare Industry, Sport Movies, Drama Movies, Comedy Movies, College, Sepracor, Cubist Pharmaceuticals, Food

Tue Jul 15, 2014

Medical Device/Diagnostic Ind.

What Does Johnson & Johnson's CEO Think of the Medtronic-Covidien Merger?

In Johnson & Johnson's second quarter 2014 earnings call today, one analyst asked chairman and CEO Alex Gorsky for his take on Gorsky's response, in essence, was that J&J saw something like this coming a mile away and beat its competitors to the punch.

Comment?

Related Topix: Food

HAPPI/Household & PP Industry

Q2 Sales Rise at J&J

Johnson & Johnson posted a 9.1% increase in sales of $19.5 billion for the second quarter of 2014.

Comment?

Related Topix: Food, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Reuters

UPDATE 3-J&J beats forecasts, helped by new hepatitis C drug

Johnson & Johnson reported higher-than-expected quarterly results on sizzling sales of its new Olysio treatment for hepatitis C, but company officials cautioned the pill will lose steam later this year as newer rivals come to market.

Comment?

Related Topix: Food, Hepatitis, Medicine, Health, Johnson & Johnson, Biotech, Johnson and Johnson, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••